SCHEMBL19821083

SCHEMBL19821083

Cc1ccccc1CSc1ccccc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
SLC1A2 P43004 1/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
DAO P14920 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16242607 0.85 POLB (0.57) SMN1; SMN2SLC1A2MAPTKMT2ACYP1A2
SCHEMBL19821082 0.84 DAO (0.51) SMN1; SMN2SLC1A2MAPTKMT2ACYP1A2
SCHEMBL17226236 0.84 KMT2A (0.54) SMN1; SMN2MAPTKMT2AHPGDALDH1A1
SCHEMBL10847537 0.80 DAO (0.51) SMN1; SMN2SLC1A2MAPTKMT2ACYP1A2
SCHEMBL29700326 0.80 POLB (0.61) SMN1; SMN2MAPTKMT2ACYP1A2CYP3A4
SCHEMBL6916799 0.80 POLB (0.61) SMN1; SMN2MAPTKMT2ACYP1A2CYP3A4
Naphthalene SCHEMBL28721345 0.79 MGAM (0.45) SMN1; SMN2MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL775626 0.78 TAAR1 (0.50) SMN1; SMN2MAPTKMT2ACYP1A2CYP3A4
SCHEMBL777337 0.78 ALDH1A1 (0.56) SMN1; SMN2MAPTKMT2ACYP1A2CYP2C9
SCHEMBL9770355 0.78 HTR7 (0.48) SMN1; SMN2MAPTALDH1A1LMNAMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180030003-A1 TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030003-A1 TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE NR1H4, SLC10A1, SLC10A2 SMN1; SMN2 4144/4885SLC1A2 799/4885MAPT 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.